Security key
761152107
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 96,983,178
- Total 13F value
- $23,361,931,740
- Share change
- +4,343,537
- Put/Call ratio
- 339%
- SEC-reported price per share
- $240.87
- Number of holders
- 941
- Value change
- +$1,010,595,349
- Number of buys
- 402
- Number of sells
- 439
- Shares outstanding
- 145,776,137
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
941
Top holders
10
RMD full security history
Ownership snapshot
Full 13F holder table
RESMED INC SEC filings
RESMED INC company facts
RESMED INC 13D/G history
Broader feeds
Ownership snapshot
Top reported holders of RMD - RESMED INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Justin Leong
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
25 Nov 2025
3/4/5
13F
Lead comparable stake: 0.02%
Showing 1-6 of 15 holder rows.
Quick read
Justin Leong leads the comparable SEC ownership view at 0.02%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Justin Leong's linked filing trail.
Comparable ownership
Top 5
Justin Leong
0.02%
Ronald R. Taylor
0.02%
Kaushik Ghoshal
0.01%
Carol J. Burt
0.01%
Richard Sulpizio
0.01%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Justin Leong |
3/4/5
Chief Product Officer
|
0.02%
|
$7,699,967
29,028 shares
|
— | 20 Nov 2025 |
| Ronald R. Taylor |
3/4/5
Director
|
0.02%
|
$6,570,755
24,771 shares
|
— | 20 Nov 2025 |
| Kaushik Ghoshal |
3/4/5
Chief Commercial Officer, SaaS
|
0.01%
|
$4,985,543
19,430 shares
|
— | 05 Aug 2025 |
| Carol J. Burt |
3/4/5
Director
|
0.01%
|
$4,991,131
18,816 shares
|
— | 20 Nov 2025 |
| Richard Sulpizio |
3/4/5
Director
|
0.01%
|
$4,720,566
17,796 shares
|
— | 19 Nov 2025 |
| Harjit Gill |
3/4/5
Director
|
0.01%
|
$2,901,944
10,940 shares
|
— | 20 Nov 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
941
Shares
96,983,178
Rows available
941
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
939
Q4 2025 holders
941
Holder diff
2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|